Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   Altered Expression of SHIP, a Toll-like Receptor Pathway Inhibitor, Is Associated With the Severity of Liver Fibrosis in Chronic Hepatitis C Virus Infection
  2. Katsounas, A.; Trippler, M.; Kottilil, S.; Lempicki, R. A.; Gerken, G.; Schlaak, J. F.
  3. Journal of Infectious Diseases. 2011, Oct; 204(8): 1181-1185.
  1. 2.   Annexin 1 Released by Necrotic Human Glioblastoma Cells Stimulates Tumor Cell Growth through the Formyl Peptide Receptor 1
  2. Yang, Y.; Liu, Y.; Yao, X. H.; Ping, Y. F.; Jiang, T.; Liu, Q.; Xu, S. L.; Huang, J.; Mou, H. W.; Gong, W. H.; Chen, K. Q.; Bian, X. W.; Wang, J. M.
  3. American Journal of Pathology. 2011, Sep; 179(3): 1504-1512.
  1. 3.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 4.   Breast cancer bone metastases Combination therapy targeting cancer cells and the tumor microenvironment
  2. de Kluyver, R. L.; Sayers, T. J.
  3. Cancer Biology & Therapy. 2010, Apr; 9(7): 551-553.
  1. 5.   Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
  2. Simunovic, F.; Yi, M.; Wang, Y. L.; Macey, L.; Brown, L. T.; Krichevsky, A. M.; Andersen, S. L.; Stephens, R. M.; Benes, F. M.; Sonntag, K. C.
  3. Brain. 2009 132: 1795-1809.
  1. 6.   Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice
  2. Hwang, S. K.; Jin, H.; Kwon, J. T.; Chang, S. H.; Kim, T. H.; Cho, C. S.; Lee, K. H.; Young, M. R.; Colburn, N. H.; Beck, G. R.; Yang, H. S.; Cho, M. H.
  3. Gene Therapy. 2007, Sep; 14(18): 1353-1361.
  1. 7.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 8.   Proteomic characterization of lipids rafts markers from the rat intestinal brush border
  2. Nguyen, H. T. T.; Amine, A. B.; Lafitte, D.; Waheed, A. A.; Nicoletti, C.; Villard, C.; Letisse, M.; Deyris, V.; Roziere, M.; Tchiakpe, L.; Danielle, C. D.; Comeau, L.; Hiol, A.
  3. Biochemical and Biophysical Research Communications. 2006, MAR 31; 342(1): 236-244.
  1. 9.   Lights on for low oxygen: A noninvasive mouse model useful for sensing oxygen deficiency
  2. Schmid, T.; Young, M. R.
  3. Molecular Interventions. 2006, Feb; 6(1): 20-22.
  1. 10.   Proline oxidase, a proapoptotic gene, is induced by troglitazone - Evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms
  2. Pandhare, J.; Cooper, S. K.; Phang, J. M.
  3. Journal of Biological Chemistry. 2006, JAN 27; 281(4): 2044-2052.
  1. 11.   Natural products as drug leads: An old process or the new hope for drug discovery?
  2. Kingston, D. G. I.; Newman, D. J.
  3. Idrugs. 2005, DEC; 8(12): 990-992.
  1. 12.   Evidence for the involvement of tyrosine kinase ZAP 70 in nuclear retinoid receptor-dependent transactivation in T lymphocytes
  2. Ishaq, M.; DeGray, G.; Natarajan, V.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34152-34158.
  1. 13.   Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis
  2. Lu, Z. X.; Ye, M.; Yan, G. R.; Li, Q.; Tang, M.; Lee, L. M.; Sun, L. Q.; Cao, Y.
  3. Cancer Gene Therapy. 2005, JUL; 12(7): 647-654.
  1. 14.   Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex
  2. Megumi, Y.; Miyauchi, Y.; Sakurai, H.; Nobeyama, H.; Lorick, K.; Nakamura, E.; Chiba, T.; Tanaka, K.; Weissman, A. M.; Kirisako, T.; Ogawa, O.; Iwai, K.
  3. Genes to Cells. 2005, JUL; 10(7): 679-691.
  1. 15.   STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker
  2. Ivanova, A.; Liao, S. Y.; Lerman, M. I.; Ivanov, S.; Stanbridge, E. J.
  3. Journal of Medical Genetics. 2005, JUL; 42(7): 565-576.
  1. 16.   Novel tumor necrosis factor-knockout mice that lack Peyer's patches
  2. Kuprash, D. V.; Tumanov, A. V.; Liepinsh, D. J.; Koroleva, E. P.; Drutskaya, M. S.; Kruglov, A. A.; Shakhov, A. N.; Southon, E.; Murphy, W. J.; Tessarollo, L.; Grivennikov, S. L.; Nedospasov, S. A.
  3. European Journal of Immunology. 2005, MAY; 35(5): 1592-1600.
  1. 17.   Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
  2. Sun, R. H.; Gao, P.; Chen, L.; Ma, D. L.; Wang, J. M.; Oppenheim, J. J.; Zhang, N.
  3. Cancer Research. 2005, FEB 15; 65(4): 1433-1441.
  1. 18.   Reactive oxygen species and lung tumorigenesis by mutant K-ras: A working hypothesis
  2. Maciag, A.; Anderson, L. M.
  3. Experimental Lung Research. 2005, JAN-FEB; 31(1): 83-104.
  1. 19.   Involvement of domain II in toxicity of anthrax lethal factor
  2. Liang, X. D.; Young, J. J.; Boone, S. A.; Waugh, D. S.; Duesbery, N. S.
  3. Journal of Biological Chemistry. 2004, DEC 10; 279(50): 52473-52478.
  1. 20.   Enhancer role of STAT5 in CD2 activation of IFN-gamma gene expression
  2. Gonsky, R.; Deem, R. L.; Bream, J.; Young, H. A.; Targan, S. R.
  3. Journal of Immunology. 2004, NOV 15; 173(10): 6241-6247.
  1. 21.   Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development
  2. Lee, S. Y.; Lee, F. S.; Moon, J. S.; Kim, J. I.; Park, J. B.; Lee, J. Y.; Park, M. J.; Kim, J.
  3. Experimental and Molecular Medicine. 2004, OCT 31; 36(5): 468-475.
  1. 22.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 23.   Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
  2. Maranchie, J. K.; Afonso, A.; Albert, P. S.; Kalyandrug, S.; Phillips, J. L.; Zhou, S.; Peterson, J.; Ghadimi, B. M.; Hurley, K.; Riss, J.; Vasselli, J. R.; Ried, T.; Zbar, B.; Choyke, P.; Walther, M. M.; Klausner, R. D.; Linehan, W. M.
  3. Human Mutation. 2004 23(1): 40-46.
  1. 24.   (Salen)Mn(III) compound as a nonpeptidyl mimic of catalase: DFT study of the metal oxidation by a peroxide molecule
  2. Abashkin, Y. G.; Burt, S. K.
  3. Journal of Physical Chemistry B. 2004 108(8): 2708-2711.
  1. 25.   Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration
  2. Akassoglou, K.; Malester, B.; Xu, J. X.; Tessarollo, L.; Rosenbluth, J.; Chao, M. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 5075-5080.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel